Patent details

EP1154767 Title: SUBSTITUTED STILBENE COMPOUNDS WITH VASCULAR DAMAGING ACTIVITY

Basic Information

Publication number:
EP1154767
PCT Application Number:
PCT/GB/2000/000503
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009038241
PCT Publication Number:
WO/2000/048590
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SUBSTITUTED STILBENE COMPOUNDS WITH VASCULAR DAMAGING ACTIVITY
French Title of Invention:
COMPOSES DE STILBENE SUBSTITUE AYANT UNE ACTIVITE DE DEGRADATION VASCULAIRE
German Title of Invention:
SUBSTITUIERTE STILBENE MIT GEFÄSSSCHÄDIGENDER AKTIVITÄT
SPC Number:

Dates

Filing date:
15/02/2000
Grant date:
15/02/2006
EP Publication Date:
15/02/2006
PCT Publication Date:
24/08/2000
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/11/2001
EP B1 Publication Date:
15/02/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/02/2006
Expiration date:
15/02/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/02/2000
 
 

Name:
Angiogene Pharmaceuticals Ltd
Address:
14 Plowden Park, Aston Rowant, Watlington, Oxfordshire OX9 5SW, United Kingdom (GB)

Inventor

Name:
DAVIS Peter, David
Address:
United Kingdom (GB)

Priority

Priority Number:
9903403
Priority Date:
16/02/1999
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 31/195;
Filing date Document type Number of pages